Stratagene has licensed for possible diagnostic development an 11-gene signature from the Sidney Kimmel Cancer Center that may predict tumor progression and metastasis, as well as identify so-called cancer stem cells.
Stratagene's best-selling diagnostics are clinical allergy tests.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
